Key Highlights

● MO shares ended 9 October 2026 at $71.64.

● Market data consensus target is $70.11 from 12 analysts.

● The second data set shows a mean of $70 and a median of $71.

● Barclays lowered its target from $64 to $58.

Altria (NYSE:MO), a member of the S&P 500, finished Friday 9 October 2026 at $71.64. The shares trade above the average analyst target. Recent broker revisions have mostly been upward.

What Is the Latest Analyst Price Target?

Market data shows a consensus 12-month target of $70.11 from 12 analysts, with a range of $58 to $79. The second data set shows a mean of $70, a median of $71 and a range of $58 to $82 from 14 analysts.

Against the $71.64 close, the consensus target implies a decline of about 2.1%. That means analysts on average see limited upside from the current price.

What Are Wall Street Analysts Saying?

Opinion is split. Market data shows five Buy, five Hold and two Sell ratings, giving a Hold consensus. The second data set shows four Strong Buy, eight Hold, one Sell and one Strong Sell among 14 analysts.

Named recent actions are sparse. On 11 August 2026 Barclays lowered its target from $64 to $58 with an Underweight rating. On 7 July UBS raised its target from $76 to $79 with a Buy rating. BTIG initiated coverage with a Neutral rating on 21 July, and Freedom Broker upgraded to Hold on 16 September without a listed target.

What Could Help the Stock Reach the Price Target?

The bull case rests on cash returns. Market data says the quarterly dividend was recently raised to $1.11 a share, or $4.44 annualised, which appeals to income-focused holders. Stable cash flow from smokeable products and growth in smoke-free alternatives could also support the shares.

UBS's $79 target and the second data set's $82 high show that some analysts see more room than the consensus suggests.

What Could Prevent the Stock Reaching the Target?

Cigarette volumes continue to decline in the US, and regulation of flavours, nicotine levels and new products is a persistent risk. Legal action and competition in smoke-free categories could also affect results.

Barclays's $58 target and Underweight rating show that bearish views exist. With the stock trading above the consensus target, further gains would require upward revisions.

What Should Investors Watch Next?

Investors may wish to follow the pace of volume declines, progress in smoke-free products, any change to the dividend and whether analysts raise targets towards the market price. The distance between the $58 low and the $82 high is wide for a mature company and suggests real disagreement.

Altria Versus Its Analyst Targets

Altria closed at $71.64 on 9 October 2026, against a market data consensus target of $70.11. On 11 August 2026 Barclays lowered its target from $64 to $58 with an Underweight rating.